These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 1865418

  • 1. Rheumatic manifestations in myelodysplastic syndromes.
    Castro M, Conn DL, Su WP, Garton JP.
    J Rheumatol; 1991 May; 18(5):721-7. PubMed ID: 1865418
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Vasculitis associated with a myelodysplastic syndrome: a report of 5 cases].
    Fernández-Miranda C, García-Marcilla A, Martín M, Gil R, Vanaclocha F, Torres N, del Palacio A.
    Med Clin (Barc); 1994 Oct 29; 103(14):539-42. PubMed ID: 7799667
    [Abstract] [Full Text] [Related]

  • 5. Childhood myelodysplastic syndromes in a Brazilian population.
    Lopes LF, Lorand-Metze I.
    Pediatr Hematol Oncol; 1999 Oct 29; 16(4):347-53. PubMed ID: 10407872
    [Abstract] [Full Text] [Related]

  • 6. Rheumatic manifestations of neoplasia.
    Brooks PM.
    Curr Opin Rheumatol; 1992 Feb 29; 4(1):90-3. PubMed ID: 1543670
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Immunologic manifestations in myelodysplastic syndrome].
    Loraas A, Lamvik J, Matre J.
    Tidsskr Nor Laegeforen; 1994 May 30; 114(14):1609-11. PubMed ID: 8079262
    [Abstract] [Full Text] [Related]

  • 9. Vasculitides associated with malignancies: analysis of sixty patients.
    Fain O, Hamidou M, Cacoub P, Godeau B, Wechsler B, Pariès J, Stirnemann J, Morin AS, Gatfosse M, Hanslik T, Belmatoug N, Blétry O, Cevallos R, Delevaux I, Fisher E, Hayem G, Kaplan G, Le Hello C, Mouthon L, Larroche C, Lemaire V, Piette AM, Piette JC, Ponge T, Puechal X, Rossert J, Sarrot-Reynauld F, Sicard D, Ziza JM, Kahn MF, Guillevin L.
    Arthritis Rheum; 2007 Dec 15; 57(8):1473-80. PubMed ID: 18050165
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The dual association between lymphoma and autoimmunity.
    Ehrenfeld M, Abu-Shakra M, Buskila D, Shoenfeld Y.
    Blood Cells Mol Dis; 2001 Dec 15; 27(4):750-6. PubMed ID: 11778659
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Phase I/II study of the mammalian target of rapamycin inhibitor everolimus (RAD001) in patients with relapsed or refractory hematologic malignancies.
    Yee KW, Zeng Z, Konopleva M, Verstovsek S, Ravandi F, Ferrajoli A, Thomas D, Wierda W, Apostolidou E, Albitar M, O'Brien S, Andreeff M, Giles FJ.
    Clin Cancer Res; 2006 Sep 01; 12(17):5165-73. PubMed ID: 16951235
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.
    Lorand-Metze I, Pinheiro MP, Ribeiro E, de Paula EV, Metze K.
    Leuk Res; 2004 Jun 01; 28(6):587-94. PubMed ID: 15120935
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pathologic sideroblastosis in myelodysplastic syndromes and acute nonlymphocytic leukemia.
    Bernardeschi P, Bonechi I.
    Recenti Prog Med; 1991 Nov 01; 82(11):588-90. PubMed ID: 1763231
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.